Data as of Q4 2025 (Dec 31, 2025)
TCE2

CELLDEX THERAPEUTICS INC NEW

Institutional Ownership · Q4 2025

Filing: Q4 2025

CELLDEX THERAPEUTICS INC NEW (TCE2) is held by 175 institutional investors with combined holdings of $1.9B. Major holders include WELLINGTON MANAGEMENT GRO, Kynam Capital Management,, BlackRock, Inc. (BLK).

💰 Dark Pool Activity👤 Insider Trades
Institutional Holders
175
Total Value
$1.9B
Ownership %
—

🏦 Top Institutional Holders

WELLINGTON MANAGEMENT GROUP LLP
8.1M shares
$219.4M
Kynam Capital Management, LP
5.9M shares
$161.4M
BlackRock, Inc. (BLK)
5.5M shares
$148.1M
FMR LLC
4.9M shares
$133.3M
VANGUARD GROUP INC
4.0M shares
$109.4M

📊 Financials

Income statement, balance sheet, and cash flow from SEC filings.

🏦 Browse Funds

See complete portfolios of top hedge funds.

🎯 AI Signals

Find stocks where multiple funds are accumulating.